Biogen Announces KCNT1 ASO in development
Viet Nguyen, MD, Medical Director, Research & Development, Biogen, Session IV: Pipeline for Gene Based Therapies.
Previous
Previous
ASO Therapies Show Promise for KCNT1
Next
Next